Osteoporosis

Postmenopausal women with osteoporosis who use denosumab as a first-line therapy have lowers risk for fractures compared with women who use alendronate, according to an industry press release.

The Healio Editors compiled news on osteoporosis in women’s health for National Women’s Health Week.

LAS VEGAS — Results presented here showed patients with osteoporosis undergoing open reduction and internal fixation for distal radius fractures had a higher risk for revision surgery compared with patients without osteoporosis.

Among postmenopausal women, consuming more dietary antioxidants was associated with decreased likelihood of osteoporosis, according to a population-based study published in Menopause.

Antiresorptive medications such as oral bisphosphonates have a minimal effect on change in lumbar spine trabecular bone score among older adults, according to a study published in The Journal of Bone and Mineral Research.

LAS VEGAS — Osteoporosis treatment started within 1 year of arthroplasty for a hip fracture was associated with a lower cumulative incidence of periprosthetic fractures vs. no osteoporosis treatment, presented data showed.

Adults with type 2 diabetes who use statins have a lower risk for hip fracture than those who do not use statins, according to data published in Diabetes/Metabolism Research and Reviews.

Pregnancy and lactation-associated osteoporosis is an uncommon diagnosis, but one that has substantial impact on fracture risk for mothers. The condition also may increase osteoporosis risk for their children later in life, an expert said.

Adults with asthma experienced more nonrespiratory diseases and multimorbidity than adults without asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Women with osteoporosis receiving abaloparatide for 18 months followed by alendronate for 2 years had greater improvements in trabecular bone score than those receiving placebo, according to study findings.